Kreicbergs A, Zetterberg A, Söderberg G
Anal Quant Cytol. 1980 Dec;2(4):272-9.
The nuclear DNA content in 48 chondrosarcomas and 4 chondromas was determined. Grading according to O'Neal-Ackerman was also performed. All chondromas were found to be diploid (normal nuclear DNA content). Twenty-two of the chondrosarcomas showed the same DNA distribution curve as the chondromas and were characterized as diploid, while 26 were found to be hyperploid (increased nuclear DNA content). A comparative study of grade and ploidy in relation to ten-year survival and metastasis rates showed that ploidy determinations in chondrosarcomas give significant prognostic information, even better than that obtained by conventional histopathologic grading. In this study, diploid chondrosarcomas were found to be associated with a significantly more favorable clinical course than were hyperploid chondrosarcomas. The prognostic relevance of these ploidy determination was further confirmed by analyzing the ploidy level of selected cases characterized bydifferent clinical courses. Thus, the tumors from 13 (93%) of 14 patients with a highly malignant clinical course (death within two years) and the tumors at the primary site in 17 (81%) of 21 metastasizing chondrosarcomas were found to be hyperploid. Direct measurements on four metastases revealed that all were hyperploid.
测定了48例软骨肉瘤和4例软骨瘤的核DNA含量。同时按照奥尼尔 - 阿克曼分级法进行了分级。所有软骨瘤均为二倍体(核DNA含量正常)。22例软骨肉瘤显示出与软骨瘤相同的DNA分布曲线,被归类为二倍体,而26例被发现为超二倍体(核DNA含量增加)。一项关于分级和倍性与十年生存率及转移率关系的对比研究表明,软骨肉瘤的倍性测定能提供重要的预后信息,甚至比传统组织病理学分级所获信息更好。在本研究中,发现二倍体软骨肉瘤的临床病程明显比超二倍体软骨肉瘤更为有利。通过分析具有不同临床病程特征的选定病例的倍性水平,进一步证实了这些倍性测定的预后相关性。因此,14例临床病程高度恶性(两年内死亡)患者中有13例(93%)的肿瘤以及21例发生转移的软骨肉瘤中17例(81%)原发部位的肿瘤被发现为超二倍体。对四个转移灶的直接测量显示,所有转移灶均为超二倍体。